The NO-donor FK409 improves mechanical properties of activated neonatal PMN

Clinical Hemorheology and Microcirculation

Volumn 51, Issue 4, 2012, Pages 293-301

  Ruef, P ^a   Craciun, E ^a   Frommhold, D ^a   Kuss, N ^a   Fritzsching, B ^a   Poschl J ^a   Koch, L ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

activation; deformability; FK 409; neonates; NO donor; PMN

Indexed keywords

4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; INTERLEUKIN 8; LEUKOCYTE ELASTASE; NITRIC OXIDE DONOR;

ADULT; ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INTRACELLULAR KILLING; LEUKOCYTE ACTIVATION; MALE; MICROCIRCULATION; NEUTROPHIL CHEMOTAXIS; NEWBORN; NORMAL HUMAN; ORGAN INJURY;

ADULT; HUMANS; INFANT, NEWBORN; INTERLEUKIN-8; LEUKOCYTE ELASTASE; MALE; MICROCIRCULATION; NEUTROPHIL ACTIVATION; NEUTROPHILS; NITRIC OXIDE DONORS; NITRO COMPOUNDS;

EID: 84865777556     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2012-1536     Document Type: Article

References (42)

1. Anonymous, Ethical guidelines for publication in Clinical Hemorheology and Microcirculation, Clin Hemorheol Microcirc 44 (2010), 1-2.
2. O.K. Baskurt, M. Boynard, G.C. Cokelet, P. Connes, B.M. Cooke, S. Forconi, F. Liao, M.R. Hardeman, F. Jung, H.J. Meiselman, G. Nash, N. Nemeth, B. Neu, B. Sandhagen, S. Shin, G. Thurston and J.L. Wautier, International expert panel for standardization of hemorheological methods. New guidelines for hemorheological laboratory techniques, Clin Hemorheol Microcirc 42 (2009), 75-97.
3. O.K. Baskurt, P. Ulker and H.J. Meiselman, Nitric oxide, erythrocytes and exercise, Clin Hemorheol Microcirc 49 (2011), 175-181.
4. M. Bl'aha, E. Rencov'a, V. Bl'aha, R. Mal'y, M. Blazek, J. Studnicka, C. Andr'ys, I. F'atorov'a, S. Filip, M. Kasparov'a, M. Proch'azkov'a, J. Mal'y, R. Zimov'a and H. Langrov'a, The importance of rheological parameters in the therapy of microcirculatory disorders, Clin Hemorheol Microcirc 42 (2009), 37-46.
5. G.L. Bloomfield, S. Holloway, P.C. Ridings, B.J. Fisher, C.R. Blocher, M. Sholley, T. Bunch, H.J. Sugerman and A.A. Fowler, Pretreatment with inhaled nitric oxide inhibits neutrophil migration and oxidative activity resulting in attenuated sepsis-induced acute lung injury, Crit Care Med 25 (1997), 584-592.
6. L.J. Bryan-Lluka, M.H. Papacostas, F.A. Paczkowski and J.C. Wanstall, Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT), Br J Pharmacol 143 (2004), 63-70.
7. J.W. Burrow, J.A. Koch, H.H. Chuang, W. Zhong, D.D. Dean and V.L. Sylvia, Nitric oxide donors selectively reduce the expression of matrix metalloproteinases-8 and -9 by human diabetic skin fibroblasts, J Surg Res 140 (2007), 90-98.
8. G. Caimi, E. Mul'e, C. Hopps, C. Carollo and R. Lo Presti, Nitric oxide metabolites and oxidative stress in mild essential hypertension, Clin Hemorheol Microcirc 46 (2010), 321-325.
9. A.A. Canalli, C.F. Franco-Penteado, S.T. Saad, N. Conran and F.F. Costa, Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation, Haematologica 93 (2008), 605-609.
10. R.R.K. Chang, N.T.Y. Chien, C.H. Chen, K.M. Jan, G.W. Schmid-Schonbein and S. Chien, Spontaneous activation of circulating granulocytes in patients with acute myocardial and cerebral diseases, Biorheology 29 (1992), 549-561.
11. R. Clancy, J. Leszczynska, A. Amin, D. Levartovsky and S.B. Abramson, Nitric oxide stimulates ADP ribosylation of actin in association with the inhibition of actin polymerization in human neutrophils, J Leukocyte Biol 58 (1995), 196-202.
12. C. Dong, R. Skalak, K.L. Sung, G.W. Schmid-Schonbein and S. Chien, Passive deformation analysis of human leukocytes, J Biomech Eng 110 (1987), 27-36.
13. G.P. Downey, E.L. Elson, B. Schwab III, C. Erzurum, S.K. Young and G.S.Worthen, Biophysical properties and microfilament assembly in neutrophils: Modulation by cyclic AMP, J Cell Biol 114 (1991), 1179-1190.
14. E.M. Drost andW. MacNee, Potential role of IL-8, platelet activating factor and TNF-a in the sequestration of neutrophils in the lung: Effects on neutrophil deformability, adhesion receptor expression, and chemotaxis, Eur J Immunol 32 (2002), 393-403.
15. N.N. Finer and K.J. Barrington, Nitric oxide for respiratory failure in infants born at or near term, Cochrane Database Syst Rev 4 (2006), CD000399.
16. S.A. Glantz, Alternatives to analysis of variance and the t-test based on ranks in: Primer of biostatistics, McGraw-Hill, New York, 1992, 105-136.
17. A. Jabs, F. Fasola, S. Muxel, T. Munzel and T. Gori, Ischemic and non-ischemic preconditioning: Endothelium-focused translation into clinical practice, Clin Hemorheol Microcirc 45 (2010), 185-191.
18. F. Jung, C. Mrowietz, U.T. Seyfert, R. Grewe and R.P. Franke, Influence of the direct NO-donor SIN-1 on the interaction between platelets and stainless steel stents under dynamic conditions, Clin Hemorheol Microcirc 28 (2003), 189-199.
19. N. Kalia, N.J. Brown, K. Hopkinson, T.J. Stephenson, R.F.Wood and A.G. Pockley, FK409 inhibits both local and remote organ damage after intestinal ischaemia, J Pathol 197 (2002), 595-602.
20. J.L. Kang,W. Park, I.S. Pack, H.S. Lee, M.J. Kim, C.M. Lim and Y. Koh, Inhaled nitric oxide attenuates acute lung injury via inhibition of nuclear factor-kappa B and inflammation, J Appl Physiol 92 (2002), 795-801.
21. S. Kanwar and P. Kubes, Nitric oxide is an antiadhesive molecule for leukocytes, New Horiz 3 (1995), 93-104.
22. Y. Kita, Y. Hirasawa, S. Fukuyama, K. Ohkubo, Y. Kato, H. Takamatsu, M. Ohno, S. Nishino, M. Kato and J. Seki, Oral biological activities of spontaneous nitric oxide releasers are accounted for by their nitric oxide-releasing rates and oral absorption manners, J Pharmacol Exp Ther 276 (1996), 421-425.
23. Y. Kita, T. Sugimoto, Y. Hirasawa, K. Yoshida and K. Maeda, Close correlation of the cardioprotective effect of FK409, a spontaneous NO releaser, with an increase in plasma cyclic GMP level, Br J Pharmacol 113 (1994), 5-6.
24. M. Kurabayashi, I. Takeyoshi, D. Yoshinari, Y. Koibuchi, T. Ohki, K. Matsumoto and Y. Morishita, NO donor ameliorates ischemia-reperfusion injury of the rat liver with iNOS attenuation, J Invest Surg 18 (2005), 193-200.
25. H. Kurata, M. Takaoka, Y. Kubo, T. Katayama, H. Tsutsui, J. Takayama, M. Ohkita and Y. Matsumura, Protective effect of nitric oxide on ischemia/reperfusion-induced renal injury and endothelin-1 overproduction, Eur J Pharmacol 517 (2005), 232-239.
26. K. Man, T.K. Lee, T.B. Liang, C.M. Lo, P.C. Fung, S.H. Tsui, X.L. Li, K.T. Ng and S.T. Fan, FK 409 ameliorates small-forsize liver graft injury by attenuation of portal hypertension and down-regulation of Egr-1 pathway, Ann Surg 240 (2004), 159-168.
27. D.C. McCurnin, R.A. Pierce, L.Y. Chang, L.L. Gibson, S. Osborne-Lawrence, B.A. Yoder, J.D. Kerecman, K.H. Albertine, V.T. Winter, J.J. Coalson, J.D. Crapo, P.H. Grubb and P.W. Shaul, Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease, Am J Physiol Lung Cell Mol Physiol 288 (2005), L450-L459.
28. V.M. Meade, C.N. Barese, C. Kim, C.G. Nijnibam, C.C. Marchal, D.A. Ingram, D.W. Clapp, M.C. Dinauer and M.C. Yoder, Rac2 concentrations in umbilical cord neutrophils, Biol Neonate 90 (2006), 156-159.
29. E. Moilanen and H. Vapaatalo, Nitric oxide in inflammation and immune response, Ann Med 27 (1995), 359-367.
30. J.M. O'Brien and E. Abraham, Human models of endotoxemia and recombinant human activated protein C, Crit Care Med 32 (2004), S202-S208.
31. F.A. Oski, Normal blood values in the newborn period, In: Hematologic problems in the newborn, OSki FA, Naiman JL eds., WB Saunders, Philadelphia, 1982, 1-31.
32. E. Rieger-Fackeldey and R. Hentschel, Bronchopulmonary dysplasia and early prophylactic inhaled nitric oxide in preterm infants: Current concepts and fututre research strategis in animal models, J Perinat Med 36 (2008), 442-447.
33. M.J. Rose, M.R. Stenger, M.S. Joshi, S.E. Welty, J.A. Bauer and L.D. Nelin, Inhaled nitric oxide decreases leukocyte trafficking in the neonatal mouse lung during exposure to >95% oxygen, Pediatr Res 67 (2010), 244-249.
34. P. Ruef, T. Bohler and O. Linderkamp, Deformability and volume of neonatal and adult leukocytes, Pediatr Res 29 (1991), 128-132.
35. P. Ruef, E. Craciun, F. Altfelder, C. Simon, D. Frommhold, L. Koch and J. Poschl, Effects of phosphodiesterase (III/IV) -inhibitors and cytokines on mechanical properties of neutrophilic granulocytes in neonates and adults, Clin Hemorhol Microcirc 45 (2010), 301-310.
36. Y. Sato, K.R.Walley, M.E. Klut, D. English,Y.D'Yachkova, J.C. Hogg and S.F. Eeden, Nitric oxide reduces the sequestration of polymorphonuclear leukocytes in lung by changing deformability and CD18 expression, Am J Respir Crit Care Med 159 (1999), 1469-1476.
37. C.P. Speer, Neonatal respiratory distress syndrome: An inflammatory disease? Neonatology 99 (2011), 316-319.
38. Z. Sun, B. Sun, X. Wang, W. Wang and L. Zhu, Anti-inflammatory effects of inhaled nitric oxide are optimized at lower oxygen concentration in experimental Klebsiella pneumoniae pneumonia, Inflamm Res 55 (2006), 430-440.
39. M. Uyuklua, H.J. Meiselman and O.K. Baskurt, Role of hemoglobin oxygenation in the modulation of red blood cell mechanical properties by nitric oxide, Nitric Oxide 21 (2009), 20-26.
40. U. Walter, Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system, Rev Physiol Biochem Pharmacol 113 (1989), 41-88.
41. T.Yasu, N. Ikeda, N. Ishizuka, E. Matsuda, M. Kawakami, M.Kuroki, N. Imai, H. Ueba, S. Fukuda,G.W. Schmid-Schonbein and M. Saito, Nicorandil and leukocyte activation, J Cardiovasc Pharmacol 40 (2002), 684-692.
42. K. Yoshida and Y. Kita, Hydroxyimine NO-donors; FK409 and derivatives, Curr Top Med Chem 5 (2005), 675-685.